Related Experiment Video
Updated: May 24, 2025
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
153
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective
Natassia Tan1,2,3, Christopher Zampogna2,3, Kate Lynch4
1Department of Gastroenterology and Hepatology, The Alfred, Melbourne, Australia.
Alimentary Pharmacology & Therapeutics
|March 3, 2025
Summary
Patient-reported outcomes in primary sclerosing cholangitis (PSC) significantly correlate with liver disease severity. This Australian study highlights the impact of PSC and inflammatory bowel disease (IBD) on quality of life.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Research
Background:
- Primary sclerosing cholangitis (PSC) is a rare liver disease often co-occurring with inflammatory bowel disease (IBD).
- PSC significantly impairs patients' health-related quality of life (HRQOL).
Purpose of the Study:
- To characterize and compare patient-reported outcomes (PROs) in PSC and IBD patients.
- To determine the correlation between PROs and liver disease severity in PSC.
Main Methods:
- A prospective, multicentre cohort study of 55 adult PSC patients in Australia.
- Validated PSC PRO questionnaires and short IBD questionnaires (SIBDQ) were administered.
- Linear regression analyzed factors associated with HRQOL and its link to liver disease severity.
Main Results:
- Mental and physical fatigue were prominent PSC symptoms.
- All HRQOL domains, except PSC symptoms, correlated with liver disease severity.
- Decompensated cirrhosis and cholangitis history reduced HRQOL; older age was protective against emotional distress.
Conclusions:
- This is the first Australian study to report PSC and IBD PROs in a prospective cohort.
- PSC-related PROs are significantly associated with liver disease severity.
- Further large-scale studies are needed to validate these findings.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
56
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
56
01:17Chronic Bowel Disorders: Introduction
376
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
376